PainReform Ltd. (PRFX)
2.63
0.05 (1.94%)
At close: Mar 24, 2025, 3:59 PM
2.66
1.32%
After-hours: Mar 24, 2025, 07:55 PM EDT
1.94% (1D)
| Bid | 2.62 |
| Market Cap | 4.49M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -209.4M |
| EPS (ttm) | -147.36 |
| PE Ratio (ttm) | -0.02 |
| Forward PE | -0.28 |
| Analyst | n/a |
| Ask | 2.71 |
| Volume | 43,306 |
| Avg. Volume (20D) | 1,204,100 |
| Open | 2.61 |
| Previous Close | 2.58 |
| Day's Range | 2.55 - 2.79 |
| 52-Week Range | 0.43 - 16.63 |
| Beta | 0.61 |
About PRFX
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the tre...
Sector Healthcare
IPO Date Sep 1, 2020
Employees 7
Stock Exchange NASDAQ
Ticker Symbol PRFX
Website https://www.painreform.com
1 month ago
+31.56%
PainReform shares are trading higher after the com...
Unlock content with
Pro Subscription
2 months ago
-28.57%
PainReform shares are trading lower. The company announced an update regarding its Phase 3 clinical trial evaluating PRF-110 in post-surgical pain management of patients undergoing bunionectomy.
